These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 34026781)

  • 1. Human-Based Advanced
    Kiener M; Roldan N; Machahua C; Sengupta A; Geiser T; Guenat OT; Funke-Chambour M; Hobi N; Kruithof-de Julio M
    Front Med (Lausanne); 2021; 8():644678. PubMed ID: 34026781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19?
    Zheng Z; Peng F; Zhou Y
    Chin Med J Pulm Crit Care Med; 2023 Jun; 1(2):77-83. PubMed ID: 37388822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis.
    Sinha S; Castillo V; Espinoza CR; Tindle C; Fonseca AG; Dan JM; Katkar GD; Das S; Sahoo D; Ghosh P
    bioRxiv; 2022 Jul; ():. PubMed ID: 34873597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiological conditions induced by SARS-CoV-2 infection reduce ACE2 expression in the lung.
    Miura Y; Ohkubo H; Nakano A; Bourke JE; Kanazawa S
    Front Immunol; 2022; 13():1028613. PubMed ID: 36405683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D In Vitro Models: Novel Insights into Idiopathic Pulmonary Fibrosis Pathophysiology and Drug Screening.
    Vazquez-Armendariz AI; Barroso MM; El Agha E; Herold S
    Cells; 2022 May; 11(9):. PubMed ID: 35563831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis.
    Sinha S; Castillo V; Espinoza CR; Tindle C; Fonseca AG; Dan JM; Katkar GD; Das S; Sahoo D; Ghosh P
    EBioMedicine; 2022 Aug; 82():104185. PubMed ID: 35870428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices.
    Alsafadi HN; Staab-Weijnitz CA; Lehmann M; Lindner M; Peschel B; Königshoff M; Wagner DE
    Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L896-L902. PubMed ID: 28314802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals.
    Al-Kuraishy HM; Batiha GE; Faidah H; Al-Gareeb AI; Saad HM; Simal-Gandara J
    Inflammopharmacology; 2022 Dec; 30(6):2017-2026. PubMed ID: 36044102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial Pulmonary Fibrosis and Extensive Dendriform Ossification with Persistent Viral Load: A Rare Presentation of Post-COVID-19 Condition in Need of Lung Transplantation.
    Haslbauer JD; Bratic-Hench I; Cima K; Luger AK; Schmitz K; Augustin F; Krapf C; Hoefer D; Tancevski I; Tzankov A; Löffler-Ragg J
    Pathobiology; 2023; 90(2):138-146. PubMed ID: 35835004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy.
    Gharaee-Kermani M; Gyetko MR; Hu B; Phan SH
    Pharm Res; 2007 May; 24(5):819-41. PubMed ID: 17333393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of ACE2 and TMPRSS2 by particulate matter and idiopathic pulmonary fibrosis: a potential role in severe COVID-19.
    Li HH; Liu CC; Hsu TW; Lin JH; Hsu JW; Li AF; Yeh YC; Hung SC; Hsu HS
    Part Fibre Toxicol; 2021 Mar; 18(1):11. PubMed ID: 33706759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients.
    Krygier A; Szmajda-Krygier D; Świechowski R; Pietrzak J; Wosiak A; Wodziński D; Balcerczak E
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The breathtaking world of human respiratory in vitro models: Investigating lung diseases and infections in 3D models, organoids, and lung-on-chip.
    Dichtl S; Posch W; Wilflingseder D
    Eur J Immunol; 2024 Mar; 54(3):e2250356. PubMed ID: 38361030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis.
    Lehmann M; Buhl L; Alsafadi HN; Klee S; Hermann S; Mutze K; Ota C; Lindner M; Behr J; Hilgendorff A; Wagner DE; Königshoff M
    Respir Res; 2018 Sep; 19(1):175. PubMed ID: 30219058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and Molecular Mechanism of Pulmonary Fibrosis Post-COVID-19: Focus on Galectin-1, -3, -8, -9.
    Oatis D; Simon-Repolski E; Balta C; Mihu A; Pieretti G; Alfano R; Peluso L; Trotta MC; D'Amico M; Hermenean A
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the ACE2/Ang-(1-7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19.
    Morganstein T; Haidar Z; Trivlidis J; Azuelos I; Huang MJ; Eidelman DH; Baglole CJ
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil Activity and Extracellular Matrix Degradation: Drivers of Lung Tissue Destruction in Fatal COVID-19 Cases and Implications for Long COVID.
    Narasaraju T; Neeli I; Criswell SL; Krishnappa A; Meng W; Silva V; Bila G; Vovk V; Serhiy Z; Bowlin GL; Meyer N; Luning Prak ET; Radic M; Bilyy R
    Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection.
    Venkataraman T; Coleman CM; Frieman MB
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28404843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectivity of mesenchymal stem cells for bleomycin-induced pulmonary fibrosis: a systematic review and implication for clinical application.
    Zhao Y; Yan Z; Liu Y; Zhang Y; Shi J; Li J; Ji F
    Stem Cell Res Ther; 2021 Aug; 12(1):470. PubMed ID: 34420515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus.
    Ekanger CT; Zhou F; Bohan D; Lotsberg ML; Ramnefjell M; Hoareau L; Røsland GV; Lu N; Aanerud M; Gärtner F; Salminen PR; Bentsen M; Halvorsen T; Ræder H; Akslen LA; Langeland N; Cox R; Maury W; Stuhr LEB; Lorens JB; Engelsen AST
    Front Cell Infect Microbiol; 2022; 12():841447. PubMed ID: 35360113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.